Depletion of death-associated protein-3 induces chemoresistance in gastric cancer cells through the β-catenin/LGR5/Bcl-2 axis
Authors:
- 1 June 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Investigative Medicine
- Vol. 67 (5) , 856-861
Abstract
Previously, we demonstrated that death-associated protein-3 (DAP3) loss drives chemoresistance in gastric cancer cells. In the present study, we aimed to determine the underlying molecular mechanism. The effect of DAP3 silencing on β-catenin signaling was assessed. The direct mediator of DAP3 silencing-induced chemoresistance was identified. Depletion of DAP3 stimulates nuclear accumulation of β-catenin and enhances β-catenin-dependent transcriptional activity in gastric cancer cells. However, the protein kinase B,, extracellular regulated protein kinase and signal transducer and activator of transcription 3 signaling pathways remain unaffected by DAP3 loss. We found that the downstream target gene LGR5 (leucine-rich G-protein coupled receptor 5) is upregulated in DAP3-depleted gastric cancer cells. Moreover, knockdown of LGR5 resensitizes DAP3-depleted gastric cancer cells to 5-fluorouracil (5-FU) and oxaliplatin. We also observed that ectopic expression of LGR5 reduces apoptosis in gastric cancer cells on treatment with 5-FU and oxaliplatin, which is accompanied by prevention of caspase-3 cleavage. The antiapoptotic protein Bcl-2 is identified as a key mediator of LGR5-induced apoptosis resistance in gastric cancer cells. The present findings indicate that DAP3 deficiency-induced chemoresistance in gastric cancer is at least partially mediated through the β-catenin/LGR5/Bcl-2 axis. Targeting LGR5 may provide a novel strategy to overcome chemoresistance in DAP3-deficient gastric cancer cells.Keywords
Funding Information
- Open Fund of Beijing Key Laboratory of Tumor invasion and metastasis
- Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support
- National Key Technology Support Program
- National Natural Science Foundation of China
This publication has 26 references indexed in Scilit:
- Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathwayBMC Cancer, 2018
- Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trialThe Lancet Oncology, 2018
- Precision medicine in the adjuvant treatment of gastric cancerThe Lancet Oncology, 2018
- Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancerCancer Biomarkers, 2018
- Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistanceCancer Letters, 2018
- LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivityBritish Journal of Cancer, 2017
- LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancerCell Death & Disease, 2017
- Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLCNature Communications, 2017
- Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistanceNature Communications, 2015
- Benefit of Adjuvant Chemotherapy for Resectable Gastric CancerJAMA, 2010